India to Australia: Letrozole Export Trade Route
India has recorded 31 verified shipments of Letrozole exported to Australia, representing a combined trade value of $875.0K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $28.2K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 43% of total export value with 14 shipments worth $377.8K USD. On the buying side, APOTEX AUSTRALIA is the largest importer in Australia with $247.6K USD in purchases. The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , INTAS PHARMACEUTICALS LIMITED — together control 93% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Australia Letrozole corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $875.0K USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 43% of all export value, reflecting the consolidated nature of India's letrozole manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $28.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with letrozole's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 32.7%, placing it at rank #9 among India's top letrozole export destinations globally.
On the import side, key buyers of Indian letrozole in Australia include APOTEX AUSTRALIA , APOTEX AUSTRALIA, TO THE ORDER OF and 8 others. APOTEX AUSTRALIA is the single largest importer with 10 shipments valued at $247.6K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ4
- Primary modeSea freight
- Top portNHAVA SHEVA SEA (INNSA1)
Market Position
- Global rank#9
- Annual growth+32.7%
- Demand growth+27.2%
- Regulatory ease82/100
Top 10 Indian Letrozole Exporters to Australia
Showing top 10 of 5 Indian suppliers exporting Letrozole to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $27.0K per shipment | 14 | $377.8K | 43.2% |
| 2 | CIPLA LIMITED Avg $25.3K per shipment | 11 | $278.2K | 31.8% |
| 3 | INTAS PHARMACEUTICALS LIMITED Avg $53.9K per shipment | 3 | $161.7K | 18.5% |
| 4 | INTAS PHARMACEUTICALS LIMITED Avg $57.1K per shipment | 1 | $57.1K | 6.5% |
| 5 | MAXWELL ENTERPRISES Avg $73 per shipment | 2 | $147 | 0.0% |
This table shows the top 10 of 5 Indian companies exporting letrozole to Australia, ranked by total trade value. The listed exporters are: CIPLA LIMITED, CIPLA LIMITED , INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , MAXWELL ENTERPRISES . CIPLA LIMITED is the dominant supplier with 14 shipments worth $377.8K USD, giving it a 43% market share. The top 3 suppliers together account for 93% of the total trade value on this route.
Top 10 Letrozole Importers in Australia
Showing top 10 of 11 known buyers in Australia receiving Letrozole shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian letrozole in Australia include APOTEX AUSTRALIA , APOTEX AUSTRALIA, TO THE ORDER OF, GENERIC HEALTH, PHARMACOR LTD. , among 11 total buyers. The largest importer is APOTEX AUSTRALIA , accounting for $247.6K USD across 10 shipments — representing 28% of all letrozole imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | APOTEX AUSTRALIA | 10 | $247.6K | 28.3% |
| 2 | APOTEX AUSTRALIA | 8 | $234.1K | 26.8% |
| 3 | TO THE ORDER OF | 2 | $109.3K | 12.5% |
| 4 | GENERIC HEALTH | 3 | $74.0K | 8.5% |
| 5 | PHARMACOR LTD. | 1 | $57.1K | 6.5% |
| 6 | ARROW PHARMACEUTICALS PTY LTD | 2 | $56.0K | 6.4% |
| 7 | TO THE ORDER., | 1 | $52.4K | 6.0% |
| 8 | GENERIC HEALTH, | 1 | $30.6K | 3.5% |
| 9 | GENERIC HEALTH.,. | 1 | $13.8K | 1.6% |
| 10 | IGOR VUCKOVECKI | 1 | $97 | 0.0% |
Showing top 10 of 11 Letrozole importers in Australia on this route.
Top 10 Letrozole Formulations Imported by Australia
Showing top 10 of 21 product formulations shipped on the India to Australia Letrozole route, ranked by trade value
Australia imports a wide range of letrozole formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LETROZOLE APOTEX 2.5 MG TABLETS (LETROZO — accounts for $234.1K USD across 9 shipments. There are 21 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LETROZOLE APOTEX 2.5 MG TABLETS (LETROZO | 9 | $234.1K | 26.8% |
| 2 | PHARMA DRUG MED PHARMACOR LETROZOLE2 5 3X10T G1 AUS EACH FILM COATED TABLETCONTAINS LETROZOLE PH EUR 2 5 MG | 2 | $109.3K | 12.5% |
| 3 | PHAR DRUG & MED : - PHARMACOR LETROZOLE | 1 | $57.1K | 6.5% |
| 4 | LETROZOLE WGR 2.5MG TABLETS (LETROZOLE2.5MG) ( INV QTY 18610 PACK 3 X 10'S = 558300 NOS) | 2 | $56.0K | 6.4% |
| 5 | PHARMA DRUGS AND MEDICINE-PHARMACOR LETROZOLE 2.5 3X10T G1(AUS EACH FILM-COATEDTABLET CONTAINS QTY.15840X3X10T | 1 | $52.4K | 6.0% |
| 6 | LETROZOLE APOTEX 2.5 MG TABLETS (LETROZOLE) (NV.QTY.18400 PACK 3 X 10S =552000NOS | 1 | $30.6K | 3.5% |
| 7 | LETROZOLE GH 2.5 MG TABLET (LETROZOLE 2. | 1 | $30.6K | 3.5% |
| 8 | LETROZOLE APOTEX 2.5 MG TABLETS (LETROZOLE) (INV.QTY.18350 PACK 3 X 10S =550500 NOS | 1 | $30.5K | 3.5% |
| 9 | LETROZOLE APOTEX 2.5 MG TABLETS LETROZOLE INV.QTY.18860 PACK 3 X 10S =565800NOS | 1 | $29.8K | 3.4% |
| 10 | LETROZOLE GH 2.5 MG TABLET LETROZOLE 2. | 1 | $29.5K | 3.4% |
Showing top 10 of 21 Letrozole formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 79%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
NHAVA SHEVA SEA (INNSA1) handles the highest volume with 14 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's letrozole exports to Australia are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 14 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , INTAS PHARMACEUTICALS LIMITED — together account for 93% of total trade value on this route. The average shipment value of $28.2K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma drug med pharmacor letrozole2 5 3x10t g1 aus each film coated tabletcontains letrozole ph eur 2 5 mg and phar drug & med : - pharmacor letrozole , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, APOTEX AUSTRALIA is the largest importer with 10 shipments worth $247.6K USD — representing 28% of all letrozole imports from India on this route. A total of 11 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $875.0K
- Avg. Shipment
- $28.2K
- Suppliers
- 5
- Buyers
- 11
- Transit (Sea)
- ~25 days
- Annual Growth
- +32.7%
Other Letrozole Routes
Unlock the Full India to Australia Letrozole Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 31 shipments on this route.
Frequently Asked Questions — India to Australia Letrozole Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Letrozole to Australia?
The leading Indian exporters of Letrozole to Australia are CIPLA LIMITED, CIPLA LIMITED , INTAS PHARMACEUTICALS LIMITED. CIPLA LIMITED holds the largest market share at approximately 43% of total trade value on this route.
Q What is the total value of Letrozole exports from India to Australia?
India exports Letrozole to Australia worth approximately $875.0K USD across 31 recorded shipments. The average value per shipment is $28.2K USD.
Q Which ports does India use to ship Letrozole to Australia?
The most active port of origin is NHAVA SHEVA SEA (INNSA1) with 14 shipments. Indian exporters primarily use sea freight for this route, with 79% of shipments going by sea and 25% by air.
Q How long does shipping take from India to Australia for Letrozole?
The average transit time for Letrozole shipments from India to Australia is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Australia Letrozole trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.7% with demand growth tracking at 27.2%. The route is ranked #9 among India's top Letrozole export destinations globally.
Q How many suppliers are active on the India to Australia Letrozole route?
There are currently 5 active Indian suppliers exporting Letrozole to Australia. The market is moderately concentrated with CIPLA LIMITED accounting for 43% of total shipment value.
Q Who are the main importers of Letrozole from India in Australia?
The leading importers of Indian Letrozole in Australia include APOTEX AUSTRALIA , APOTEX AUSTRALIA, TO THE ORDER OF, GENERIC HEALTH, PHARMACOR LTD. . APOTEX AUSTRALIA is the largest buyer with 10 shipments worth $247.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Letrozole.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 11 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 31 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
31 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists